These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Parkinson's disease. Clarke CE; Moore AP Am Fam Physician; 2007 Apr; 75(7):1045-8. PubMed ID: 17427619 [No Abstract] [Full Text] [Related]
9. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
10. Optimizing clinical outcomes in residents with Parkinson's disease. Introduction. Libow LS J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):3. PubMed ID: 17948615 [No Abstract] [Full Text] [Related]
11. [Early treatment of Parkinson's disease with levodopa]. Odekerken VJ; Post B; Verschuur CV; de Bie RM Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822 [TBL] [Abstract][Full Text] [Related]
12. Population prevalence and incidence of Parkinson's disease in an Australian community. Mehta P; Kifley A; Wang JJ; Rochtchina E; Mitchell P; Sue CM Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942 [TBL] [Abstract][Full Text] [Related]
13. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease. Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256 [TBL] [Abstract][Full Text] [Related]
14. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort Investigators Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655 [TBL] [Abstract][Full Text] [Related]
15. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Toth C; Breithaupt K; Ge S; Duan Y; Terris JM; Thiessen A; Wiebe S; Zochodne DW; Suchowersky O Ann Neurol; 2010 Jul; 68(1):28-36. PubMed ID: 20582991 [TBL] [Abstract][Full Text] [Related]
16. Interpreting the results of Parkinson's disease clinical trials: time for a change. Holford NH; Nutt JG Mov Disord; 2011 Mar; 26(4):569-77. PubMed ID: 21370266 [TBL] [Abstract][Full Text] [Related]